XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Grant and collaboration revenues $ 110,417 $ 715,977
Operating expenses:    
Research and development 602,783 808,936
General and administrative 1,071,710 502,345
Total operating expenses 1,674,493 1,311,281
Loss from operations (1,564,076) (595,304)
Other income (expense):    
Interest income 2,053 752
Interest expense (755) (1,142)
Total other income (expense) 1,298 (390)
Net loss $ (1,562,778) $ (595,694)
Basic and diluted:    
Net loss per common share (in dollars per share) $ (0.29) $ (2.54)
Weighted average shares outstanding (in shares) 5,332,058 234,395